Health on the Hill: House Republicans attack Obama administration on Medicare Advantage

Download PDF Copy

Sep 25 2012

NewsGuard 100/100 Score

In this edition of Health on the Hill, Kaiser Health News' Mary Agnes Carey interviews CQ Roll Call's Emily Ethridge about last week's House Ways and Means health subcommittee hearing on the health law's cuts to the private Medicare Advantage program (9/21).

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Healthcare News

Tags: Health Care, Hearing, Medicare, Research

Comments (0)

Download PDF Copy

Suggested Reading

Transparency and rigorous oversight urged for U.S. Medicare Advantage program

Transparency and rigorous oversight urged for U.S. Medicare Advantage program

Study warns of high Medicare costs for semaglutide even with restrictive CVD definition

Study warns of high Medicare costs for semaglutide even with restrictive CVD definition

Medicare coverage for obesity drug raises questions

Medicare coverage for obesity drug raises questions

Election outcome could bring big changes to Medicare

Election outcome could bring big changes to Medicare

New analysis raises concerns over Medicare Advantage spending for veterans

New analysis raises concerns over Medicare Advantage spending for veterans

Medicare choices spark revolving door for older adults

Medicare choices spark revolving door for older adults

Medicare drug plans are getting better next year. some will also cost more.

Medicare drug plans are getting better next year. some will also cost more.

Feds killed plan to curb Medicare Advantage overbilling after industry opposition

Feds killed plan to curb Medicare Advantage overbilling after industry opposition

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

New vial size could save Medicare millions on Alzheimer's drug